AnuBio

What it does

"AnuBio is a pioneering company in the fields of Artificial Intelligence, Deeptech, and Health, dedicated to reprogramming immunomodulation for cancer treatment. Utilizing phenotypic drug discovery of combinatorial biologics, AnuBio has developed a pair of groundbreaking technologies that enhance the discovery of novel immunomodulators by 100-fold. These technologies include PHENOMS, a proprietary in vitro phenotypic screening platform combined with multispecific biologics, and TRAILBLAZER AI, a revolutionary architecture AI model of the immune system. By synergizing these technologies, AnuBio has created a closed-loop lab-AI research platform that integrates real-world data and validation from PHENOMS with predictive insights from TRAILBLAZER AI. This innovative approach streamlines the drug discovery process, offering valuable predictions for success at every stage."